Currently out of the existing stock ratings of Liana Moussatos, 261 are a BUY (91.9%), 23 are a HOLD (8.1%).

Liana Moussatos

Work Performance Price Targets & Ratings Chart

Analyst Liana Moussatos, carries an average stock price target met ratio of 47.18% that have a potential upside of 49.87% achieved within 427 days. Previously, Liana Moussatos worked at WEDBUSH.

Liana Moussatos’s has documented 559 price targets and ratings displayed on 41 stocks. The coverage was on Healthcare, Technology, Basic Materials, Financial Services sectors.

Most recent stock forecast was given on CLSD, Clearside Biomedical at 12-Mar-2024.

Wall Street Analyst Liana Moussatos

Analyst best performing recommendations are on GRAY (GRAYBUG VISION).
The best stock recommendation documented was for GRAY (GRAYBUG VISION) at 3/9/2021. The price target of $112 was fulfilled within 2 days with a profit of $11.2 (11.11%) receiving and performance score of 55.56.

Average potential price target upside

AIMT Aimmune Therapeutics ALBO Albireo Pharma AQST Aquestive Therapeutics ASND Ascendis Pharma AS BMRN Biomarin Pharmaceutical BPMC Blueprint Medicines Corp CATB Catabasis Pharmaceuticals CLSD Clearside Biomedical ICPT Intercept Pharmaceuticals LQDA Liquidia Technologies LXRX Lexicon Pharmaceuticals OMER Omeros PCRX Pacira Pharmaceuticals RGLS Regulus Therapeutics RLYP Relypsa SGMO Sangamo Therapeutics UTHR United Therapeutics VRNA Verona Pharma PLC ADR XOMA XOMA Corp AXLA Axcella Health GRAY Graybug Vision IMUX Immunic MGEN Viridian Therapeutics EIGR Eiger Biopharmaceuticals OBSV ObsEva SA ATXS Astria Therapeutics GBT Global Blood Therapeutics ALNA Allena Pharmaceuticals KALA Kala Pharmaceuticals KALV Kalvista Pharmaceuticals KRTX Karuna Therapeutics LRMR Larimar Therapeutics AI C3 Ai ALB Albemarle Corp AVT Avnet AX Axos Financial CLS Celestica EIG Employers Holdings GBTG Global Business Travel Group KRT Karat Packaging MG Mistras Group

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 19-Dec-2019

$18

6 years 1 months ago
(01-Sep-2020)

3/3 (100%)

$3.19 (21.54%)

78

Buy Since 14-Jun-2016

$34.5

$0.01 (0.03%)

$66

6 years 1 months ago
(31-Aug-2020)

1/9 (11.11%)

$0.28 (0.82%)

39

Hold Since 04-Feb-2020

$34.5

$0.01 (0.03%)

6 years 1 months ago
(31-Aug-2020)

5/5 (100%)

$0.28 (0.82%)

138

Buy Since 17-Nov-2015

$35

$0.51 (1.48%)

6 years 1 months ago
(31-Aug-2020)

5/14 (35.71%)

$0.78 (2.28%)

488

Buy Since 03-Jun-2019

$60

6 years 1 months ago
(31-Aug-2020)

0/19 (0%)

$41.31 (221.03%)

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?